MTOR and breast cancer: In an intraperitoneal xenograft mouse model constructed with MDA-MB-231 cells, Rd significantly reduced the volume and weight of breast cancer tumor tissues, decreased tumor angiogenesis, and inhibited breast cancer cell proliferation by suppressing Akt/mTOR/p70S6 kinase signaling in a dose-dependent manner.